In the 35 years before the COVID-19 pandemic, the U.S. government invested at least $337 million into critical research that led to the mRNA COVID-19 vaccines, according to a study published by The BMJ today.
Mar 1, 2023
0
88
You might not have heard of respiratory syncytial virus, or RSV. But it caused more than 100,000 global deaths in 2019, making it a leading cause of death in children under one year old.
Feb 27, 2023
0
9
A team of medical researchers from Amyris, Inc. and the Access to Advanced Health Institute has developed a new way to synthesize squalene, a natural terpene used to boost the effectiveness of several vaccines. In their paper ...
Many vaccine trials use age de-escalation with the goal of safeguarding the interests of younger, more vulnerable populations. After a vaccine's safety and efficacy are established in adult populations, progressively younger ...
Feb 21, 2023
0
20
The COVID-19 Prevention Network (CoVPN), headquartered at Fred Hutchinson Cancer Center in Seattle, was instrumental in the rapid development of safe, effective and lifesaving COVID-19 vaccines during earlier phases of the ...
Jan 24, 2023
0
10
A review of the COVID-19 vaccine trials indicate that adenovirus vectored vaccines may have non-specific protective effects resulting in significantly reduced all-cause mortality and non-COVID deaths, compared with mRNA based ...
Jan 19, 2023
0
4
Former federal MP Dr. Kerryn Phelps has talked this week about the medical problems she and her wife had after their COVID-19 vaccinations around 18 months ago.
Dec 22, 2022
0
9
COVID-19 vaccinations that combine two or more distinct variants of the SARS-CoV-2 virus could offer protection against both current and future "variants of concern," say scientists at the University of Cambridge and Medical ...
Dec 14, 2022
0
52
A nasal COVID-19 vaccine based on technology licensed from Washington University in St. Louis has been approved for emergency use in India as a booster for people who have already received two doses of other COVID-19 vaccines. ...
Dec 12, 2022
0
28
Tulane University researchers are working on a new Chagas disease vaccine that prevents lasting heart damage, a long-term complication from the tropical disease.
Dec 12, 2022
0
4
